Skip to main content

CEL-SCI Corp (CVM) Stock

CEL-SCI Corp Stock Details, Movements and Public Alerts

Stock Details

CEL-SCI Corp (CVM), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NYSE MKT.Currently, the stock is trading at $3.58. Over the past 52 weeks, it has ranged between $1.98 and $16.20. This places the current price at 22.1% of its 52-week high and 80.8% above its 52-week low. Recent trading volume was recorded at 27,219. The 14-day Relative Strength Index (RSI) stands at 51.14, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $5.90 by 39.32%. Similarly, it is below its 200-day moving average of $6.72 by 46.73%. The MACD histogram is 0.13, indicating bullish momentum (MACD Line: 0.08, Signal Line: -0.05).

52-Week Range

$16.20 - $1.98

-77.90% from high · +80.81% from low

Avg Daily Volume

79,147

20-day average

100-day avg: 92,459

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

PEG Ratio

0.00

Potentially undervalued

Price to Book

2.58

EV/EBITDA

-3.71

EPS (TTM)

-$6.27

Price to Sales

11797.42

Beta

0.82

Less volatile than market

Q:How is CVM valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is CVM's risk profile compared to the market?
With a beta of 0.82, CEL-SCI Corp is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 2.58 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-22,724,584

Return on Equity

-176.30%

Return on Assets

-56.20%

Revenue Growth (YoY)

-62.70%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is CVM's business model?
Profitability metrics are not available for this stock.
Q:What are CVM's recent growth trends?
CEL-SCI Corp's revenue declined by 62.70% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions.0 These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$42.0M

Revenue (TTM)

$28,560

Revenue/Share (TTM)

$0.00

Shares Outstanding

8.41M

Book Value/Share

$1.99

Asset Type

Common Stock

Q:What is CVM's market capitalization and position?
CEL-SCI Corp has a market capitalization of $42.0M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 8.41M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
Q:How does CVM's price compare to its book value?
CEL-SCI Corp's book value per share is $1.99, while the current stock price is $3.58, resulting in a price-to-book (P/B) ratio of 1.80. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$42.50

1087.15% upside potential

Analyst Recommendations

No analyst ratings available

Q:How reliable are analyst predictions for CVM?
0 analysts cover CVM with 0% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $42.50 implies 1087.2% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on CVM?
Current analyst recommendations:The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Feb 8, 2026, 02:50 AM

Technical Indicators

RSI (14-day)

51.14

Neutral

50-Day Moving Average

$5.90

-39.32% below MA-50

200-Day Moving Average

$6.72

-46.73% below MA-200

MACD Line

0.08

MACD Signal

-0.05

MACD Histogram

0.13

Bullish

Q:What does CVM's RSI value tell investors?
The RSI (Relative Strength Index) for CVM is currently 51.14, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this shows mixed signals requiring careful analysis.
Q:How should traders interpret CVM's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.08 above the signal line at -0.05, with histogram at 0.13. This bullish crossover suggests upward momentum is building. The 50-day MA ($5.90) is below the 200-day MA ($6.72), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Jan 30, 2026, 12:31 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for CVM and get notified when the price changes.

Stay Ahead of the Market with CEL-SCI Corp Alerts

Set up price alerts for CEL-SCI Corp and get notified instantly when the price hits your target. Never miss an important price movement again.